Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02354664 · ClinicalTrials.gov registry record

Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease

A clinical trial, sponsored by University of Florida.

Completed
Registry status
14
Enrollment target

NCT02354664: Completed study, sponsored by University of Florida.

NCT02354664 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02354664 has completed, sponsored by University of Florida.

COMPLETED
Registry status
14 participants
Enrollment target

Study Summary

This study intends to evaluate dynamic respiratory motor performance as a valuable measure of pulmonary function in adults with late-onset Pompe disease. The investigators will adopt a strategy that includes comprehensive evaluations of respiratory volume, flow, and timing parameters during resting and loaded breathing. These evaluations will then be associated to the standard clinical measure of maximal inspiratory pressure, the static inspiratory muscle function, as well as magnetic resonance imaging of thoracic expansion and diaphragmatic descent at rest and with exertion. Outcomes in participants with late-onset Pompe disease will be contrasted to the function of age- and gender-matched control subjects. This approach will enable the investigators to evaluate the relationship between dynamic diaphragmatic function and respiratory motor function.

Primary Outcome

For ILC testing, a commercially available, spring-loaded device provided a pressure load to inspiration that is independent of inspiratory flow. The patient had to generate enough threshold inspiratory pressure in order to receive airflow. The tension of the spring was adjusted to regulate the threshold pressure of the imposed load. Volume, flow and timing responses were evaluated to an inspiratory threshold load equivalent to 40% of PImax.

Interventions

  • OTHER Spirometry
  • OTHER Thoracic MRI
  • OTHER Inspiratory Load Compensation
  • OTHER Maximal Inspiratory Pressure
  • OTHER Resting Breathing Pattern

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2015-04
Est. Completion 2016-10-19
University of Florida

1,106 total trials

What the finished NCT02354664 record still lists

NCT02354664 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which Spirometry is the first listed.

NCT02354664 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02354664 about?

NCT02354664 is a clinical study titled "Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease". This study intends to evaluate dynamic respiratory motor performance as a valuable measure of pulmonary function in adults with late-onset Pompe disease. The investigators will adopt a strategy that includes comprehensive evaluations of respiratory volume, flow, and timing parameters during resting ...

What is the current status of trial NCT02354664?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2015-04. Estimated completion is 2016-10-19.

What interventions are being tested in trial NCT02354664?

The interventions under investigation include: Spirometry (OTHER), Thoracic MRI (OTHER), Inspiratory Load Compensation (OTHER), Maximal Inspiratory Pressure (OTHER), Resting Breathing Pattern (OTHER).

Who is sponsoring clinical trial NCT02354664?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02354664, the US trial registry maintained by the National Library of Medicine. NCT02354664 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.